Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03179904
Brief Title: FASN Inhibitor TVB-2640, Paclitaxel, and Trastuzumab in Treating Patients With HER2 Positive Advanced Breast Cancer

First Submitted : May 30, 2017
First Submitted that Met QC Criteria : June 6, 2017
First Posted : June 7, 2017

Last Update Submitted that Met QC Criteria : August 13, 2018
Last Update Posted : August 14, 2018